Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead

Description

For women undergoing percutaneous nerve evaluation (PNE) for the treatment of overactive bladder the first step is the PNE interstim therapy trial. If the PNE works, patients may opt to have the interstim procedure. The purpose of this study is to see if patients who remove their PNE lead at home have the same satisfaction with the PNE trial as those women who have their lead removed in the office.

Conditions

Overactive Bladder

Study Overview

Study Details

Study overview

For women undergoing percutaneous nerve evaluation (PNE) for the treatment of overactive bladder the first step is the PNE interstim therapy trial. If the PNE works, patients may opt to have the interstim procedure. The purpose of this study is to see if patients who remove their PNE lead at home have the same satisfaction with the PNE trial as those women who have their lead removed in the office.

A Randomized Trial Comparing Home verSus In-office Removal of the percuTaneous Nerve evaluatIon Lead perforMed for the Treatment of Overactive Bladder in Women (STIM Trial)

Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead

Condition
Overactive Bladder
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age greater than or equal to 18 years of age
  • * Patients undergoing sacral neuromodulation (SNM) for urinary urgency incontinence or urgency-frequency syndrome
  • * Inability to comprehend written and/or spoken English
  • * Inability to provide informed consent
  • * Patients undergoing SNM for other indications (e.g. urinary retention, fecal incontinence,)
  • * Previous SNM treatment
  • * No home support to assist with lead removal

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Cleveland Clinic,

Cecile A. Ferrando, M.D., PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2025-12